Two numbers decide most of it: a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a health condition tied to weight. Those are the thresholds the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) gives for weight management medicines, and they match the adults studied for the FDA approved semaglutide and tirzepatide products. The rest is your health history, your family’s, the medicines you already take, and any pregnancy plans, which is why the answer comes from an evaluation and not from a calculator.

GLP-1 Eligibility at a Glance

  • BMI of 30 or higher: meets the threshold on its own.
  • BMI of 27 to 29.9: meets the threshold with at least one weight-related condition.
  • Conditions that count: high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, and heart disease are the ones the sources name.
  • Who should not take them: anyone with a personal or family history of medullary thyroid cancer or MEN 2, or a past serious allergic reaction to the medicine.
  • Pregnancy: not during pregnancy or while planning one.
  • Age: adults. Semaglutide injection is also approved for ages 12 and older with obesity; tirzepatide is for adults only.
  • What goes with the medicine: a reduced-calorie diet and more physical activity.
  • Who decides: a licensed prescriber, after an evaluation.

The BMI Thresholds

A BMI of 30 or higher is the range health agencies call obesity, and it meets the threshold on its own. A BMI of 27 to 29.9 sits in the overweight range and meets it only when a weight-related condition comes with it. Under 27, you’re outside the group these medicines were studied in for weight management.

BMI is a starting measure. Two people at the same BMI can carry very different amounts of muscle and fat, so at Qvita we also run a body composition analysis on the InBody 380, which shows how much of your weight is muscle, fat, and water. It takes about 30 seconds.

The Health Conditions That Count

High blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, and heart disease are the weight-related conditions named in the tirzepatide studies and by NIDDK. For an adult with a BMI of 27 to 29.9, one of them is what brings the medicines into the conversation.

Blood sugar and cholesterol are both on the blood work we draw in the office, and we check blood pressure at the visit. If you already manage high blood pressure or type 2 diabetes with us, say so. It’s part of the same decision.

Who Should Not Take Semaglutide or Tirzepatide

Anyone who has had medullary thyroid cancer, or has a family member who has, should not take either medicine. The same goes for people with the endocrine condition called MEN 2 and for anyone who has had a serious allergic reaction to the medicine or its ingredients. Both carry a boxed warning about thyroid C-cell tumors, so the family history question comes first. I think it’s the one people most often can’t answer on the spot. Ask your relatives before you come in.

Taking either one together with another GLP-1 medicine isn’t recommended.

Pregnancy changes the answer. The Medication Guides for both say the medicine may harm an unborn baby. The semaglutide guide says to stop two months before a planned pregnancy, and the tirzepatide guide warns that birth control pills may not work as well for four weeks after starting and for four weeks after each dose increase. Tell your prescriber if you’re breastfeeding or plan to.

The guides also list things to tell your prescriber before you start. These aren’t on the do-not-use list, but your prescriber needs to know about each one before deciding:

  • Problems with your pancreas or kidneys, now or in the past
  • Severe stomach problems, such as slowed stomach emptying (gastroparesis)
  • A history of diabetic retinopathy
  • Diabetes medicines, especially insulin or a sulfonylurea
  • Surgery or another procedure with anesthesia or deep sedation coming up
  • Every other medicine, vitamin, and supplement you take

If Your BMI Is Under the Threshold

Below a BMI of 27, or below 30 with no weight-related condition, you’re outside the group these medicines were studied in for weight management. Being over the threshold doesn’t make a prescription automatic either. NIDDK says weight management medicines aren’t for everyone with a high BMI, and that a program built around eating, activity, and other habits is enough for some people.

Our medical weight loss program has more in it than a prescription. It includes a diet plan with recipes, body composition tracking, and regular contact with your provider and our staff, and we see people with a wide range of goals. Whether medicine belongs in your plan gets decided at the visit.

What the Evaluation Covers

Eligibility is decided at an evaluation, and at Qvita it starts with your health history, your medicine list, and blood work drawn in our office. The in-office labs check a complete blood count (CBC), thyroid function, blood sugar, and cholesterol. We also go over your day-to-day habits, because these medicines are meant to be used with a reduced-calorie diet and more physical activity.

Semaglutide and tirzepatide are the two GLP-1 weight loss medications we prescribe. Come with your medicine list, what you know of your family’s thyroid history, and the date of any surgery you have scheduled.

Qualifying and Coverage Are Separate Questions

Meeting the medical criteria doesn’t mean an insurance plan will pay. Some plans cover weight management medicines and some don’t, and getting GLP-1 medications covered by insurance has its own steps. Our team can go over your options with you, including self-pay pricing and payment plans.

Questions About Qualifying

Do You Need Diabetes to Qualify for a GLP-1 Weight Loss Medication?

Diabetes isn’t a requirement. For weight management the starting point is BMI, and type 2 diabetes is one of the conditions that counts for adults with a BMI of 27 to 29.9.

Can You Get a GLP-1 Medication With a BMI of 27?

A BMI of 27 to 29.9 meets the threshold when at least one weight-related condition is present, such as high blood pressure or high cholesterol. Without one, the threshold is 30.

Do You Need Blood Work Before Starting?

At Qvita, the program starts with blood work. It’s drawn in our office and includes a complete blood count (CBC), thyroid function, blood sugar, and cholesterol.

Can You Take Semaglutide or Tirzepatide While Trying to Get Pregnant?

Neither medicine is meant for pregnancy or for the months leading up to one. NIDDK’s advice is never to take weight management medicines during pregnancy or while planning one, and the semaglutide guide says to stop two months before.

Do You Have to Stay on the Medicine Once You Start?

You’ll probably regain some weight after stopping, according to NIDDK. When you reach your goal, we offer a maintenance program to help you transition gradually.

Keep Reading

Sources

Book a Weight Loss Evaluation in Wesley Chapel

Call Qvita Health and Wellness at (813) 501-4130 or book online.

Call Us Appointments

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset